Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Illumina
(NASDAQ:ILMN)
Intraday
$122.28
1.23
[1.02%]
After-Hours
$122.28
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$122.28
1.23
[1.02%]
At close: Apr 26
$122.28
0
[0.00%]
After Hours: 4:00PM EDT
Get Report
Watch
Q1 2024 Earnings in 5 days from now on Thu May 2nd, after the market close
Conference call scheduled in 5 days at 17:00 PM
Click to view the webcast
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Illumina Stock (NASDAQ:ILMN)
Illumina Stock (NASDAQ: ILMN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, April 23, 2024
Shares of life sciences tools stocks are trading higher following strong earnings from Danaher.
Benzinga Newsdesk
-
4 days ago
Tuesday, April 16, 2024
What the Options Market Tells Us About Illumina
Benzinga Insights
-
Apr 16, 2024, 10:46AM
Friday, April 12, 2024
Looking Into Illumina's Recent Short Interest
Benzinga Insights
-
Apr 12, 2024, 11:45AM
EU Approved Illumina's Plan To Divest Grail
Charles Gross
-
Apr 12, 2024, 5:48AM
Wednesday, April 10, 2024
Barclays Maintains Underweight on Illumina, Raises Price Target to $100
Benzinga Newsdesk
-
Apr 10, 2024, 3:30PM
Stephens & Co. Reiterates Overweight on Illumina, Maintains $170 Price Target
Benzinga Newsdesk
-
Apr 10, 2024, 8:38AM
Tuesday, April 09, 2024
Illumina Appoints Ankur Dhingra Chief Financial Officer; Co. Reaffirms Q1 And 2024 Guidance
Benzinga Newsdesk
-
Apr 9, 2024, 4:05PM
RBC Capital Reiterates Outperform on Illumina, Maintains $253 Price Target
Benzinga Newsdesk
-
Apr 9, 2024, 9:32AM
Monday, April 08, 2024
Jim Cramer Isn't Going With This Tech Company: 'It's Complicated. I'm A Nvidia Guy'
Avi Kapoor
-
Apr 8, 2024, 8:26AM
Wednesday, March 27, 2024
GRAIL Presents New Data On Galleri And Its Methylation Platform At The Annual American Association For Cancer Research Meeting
Benzinga Newsdesk
-
Mar 27, 2024, 9:03AM
Thursday, March 21, 2024
EU Antitrust Regulators Overstepped in Illumina-Grail Deal, Says Court Adviser
Vandana Singh
-
Mar 21, 2024, 1:56PM
Illumina shares are trading higher after a European court reportedly ruled that EU antitrust regulators exceeded their powers by blocking the company's bid for Grail.
Benzinga Newsdesk
-
Mar 21, 2024, 9:14AM
Illumina Shares Higher After Europe's Top Court Said EU Antitrust Regulators Exceeded Powers By Blocking Bid For Grail
Charles Gross
-
Mar 21, 2024, 7:54AM
Wednesday, March 20, 2024
OTR Global Downgrades Illumina to Mixed
Benzinga Newsdesk
-
Mar 20, 2024, 11:55AM
Monday, March 18, 2024
GRAIL Announces Novel Risk Classification Test On Its Methylation Platform To Be Used In Lung Cancer Study
Happy Mohamed
-
Mar 18, 2024, 9:01AM
Wednesday, March 13, 2024
Gene Sequencing Firm Illumina Escapes Carl Icahn's Second Proxy Battle Amid Grail Divestment Efforts
Vandana Singh
-
Mar 13, 2024, 1:56PM
Tuesday, March 12, 2024
Illumina shares are trading lower after Carl Icahn reportedly dropped a threat to start another proxy battle with the board.
Benzinga Newsdesk
-
Mar 12, 2024, 3:38PM
Carl Icahn Drops Threat To Challenge Illumina's Board Of Directors, Sources Say
Benzinga Newsdesk
-
Mar 12, 2024, 1:37PM
Thursday, March 07, 2024
A Closer Look at Illumina's Options Market Dynamics
Benzinga Insights
-
Mar 7, 2024, 11:46AM
Tuesday, February 27, 2024
Over $1M Bet On This Industrial Stock? Check Out These 4 Stocks Insiders Are Buying
Avi Kapoor
-
Feb 27, 2024, 8:47AM
Wednesday, February 14, 2024
Critical Insights From Illumina Analyst Ratings: What You Need To Know
Benzinga Insights
-
Feb 14, 2024, 12:00PM
Stephens & Co. Reiterates Overweight on Illumina, Maintains $170 Price Target
Benzinga Newsdesk
-
Feb 14, 2024, 11:23AM
Friday, February 09, 2024
Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
-
Feb 9, 2024, 1:18PM
RBC Capital Reiterates Outperform on Illumina, Maintains $258 Price Target
Benzinga Newsdesk
-
Feb 9, 2024, 11:23AM
Illumina shares are trading lower following Q4 financial results.
Benzinga Newsdesk
-
Feb 9, 2024, 11:07AM
DNA Sequencing Kit Provider Illumina's Q4 Earnings Edge Above Street Estimates, Works To Resolve GRAIL Quickly
Vandana Singh
-
Feb 9, 2024, 9:32AM
US Stocks Set To Open Higher, Finish Week Stronger Amid Mixed Earnings: Analyst Sees Another Leg-Up Ahead Of Historically Weak March
Shanthi Rexaline
-
Feb 9, 2024, 7:32AM
Expedia Reports Q4 Results, Joins Pinterest, Affirm Holdings And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Avi Kapoor
-
Feb 9, 2024, 4:57AM
Thursday, February 08, 2024
Illumina Sees FY24 Core Illumina Revenue Approx. Flat YoY
Benzinga Newsdesk
-
Feb 8, 2024, 4:07PM
Illumina Q4 2023 Adj EPS $0.14 Beats $0.02 Estimate, Sales $1.12B Beat $1.09B Estimate
Benzinga Newsdesk
-
Feb 8, 2024, 4:06PM
S&P 500 Tests Resistance At 5,000, ARM Rockets, Oil Rebounds: What's Driving Markets Thursday?
Piero Cingari
-
Feb 8, 2024, 2:05PM
US Stocks On Backfoot Amid Overbought Levels, S&P 500 Eyes Break Above 5K: Analyst Sees 'Dramatically Higher' Market Surge From Rally This Year
Shanthi Rexaline
-
Feb 8, 2024, 7:34AM
Earnings Scheduled For February 8, 2024
Benzinga Insights
-
Feb 8, 2024, 4:43AM
Wednesday, February 07, 2024
Earnings Preview For Illumina
Benzinga Insights
-
Feb 7, 2024, 2:00PM
Friday, January 26, 2024
(ILMN) - Analyzing Illumina's Short Interest
Benzinga Insights
-
Jan 26, 2024, 1:15PM
Thursday, January 25, 2024
Analyst Ratings For Illumina
Benzinga Insights
-
Jan 25, 2024, 10:01AM
Barclays Maintains Underweight on Illumina, Raises Price Target to $80
Benzinga Newsdesk
-
Jan 25, 2024, 9:48AM
Wednesday, January 24, 2024
Jim Cramer: Stay Away From This Major Airline Stock, 'People Should Understand Airlines Are Trades'
Avi Kapoor
-
Jan 24, 2024, 8:52AM
Tuesday, January 16, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
-
Jan 16, 2024, 12:35PM
Monday, January 15, 2024
Concentric By Ginkgo Has Entered Into A Co-Marketing Agreement With Illumina To Partner On Expanding Biosecurity Capabilities Globally
Benzinga Newsdesk
-
Jan 15, 2024, 6:24PM
Tuesday, January 09, 2024
Why JetBlue Airways Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
-
Jan 9, 2024, 1:00PM
Live On CNBC, Amy Raskin's Contrarian Idea: Illumina, Inc.
Benzinga Newsdesk
-
Jan 9, 2024, 12:40PM
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
-
Jan 9, 2024, 12:35PM
Illumina Exec Says Expect That Co's China Business Will Still Be Challenged In 2024
Benzinga Newsdesk
-
Jan 9, 2024, 12:35PM
Illumina Exec Says Expect 2024 Results Will Be Very Similar To 2023; Expect Customers To Remain Cautious & Constrained In Their Purchasing Decisions; Co Will Continue To Make Inorganic Investments
Benzinga Newsdesk
-
Jan 9, 2024, 12:24PM
Illumina Shares Trading Higher After Confirming Partnership With Johnson & Johnson Unit
Nabaparna Bhattacharya
-
Jan 9, 2024, 11:50AM
Acuity Brands Posts Upbeat Earnings, Joins Accolade, Urban Outfitters And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
-
Jan 9, 2024, 10:59AM
Illumina shares are trading higher after the company reported preliminary Q4 and FY23 consolidated revenue guidance above estimates.
Benzinga Newsdesk
-
Jan 9, 2024, 10:15AM
Illumina Prelim. 2023 Consolidated Revenue $4.497B vs $4.45B Est.
Benzinga Newsdesk
-
Jan 9, 2024, 9:02AM
Illumina Prelim. Q4 Consolidated Revenue $1.115B vs $1.07B Est.
Benzinga Newsdesk
-
Jan 9, 2024, 9:01AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch